Top

Published in:

01-09-2017 | Original Paper

Autoantibodies to desmogleins 1 and 3 in patients with lichen planus

Authors: Lajevardi Vahide, Halaji Zahra, Ghaedi Forugh, Saljoughi Nazi

Published in: Archives of Dermatological Research | Issue 7/2017

Abstract

There is controversy about the role of autoantibodies against desmoglein 1 and 3 (Dsg1 and 3) in the pathogenesis of lichen planus (LP); the authors planned this study to determine the presence of circulating levels of these antibodies in patients with different types of oral LP and to compare that with cutaneous LP and healthy controls. The enzyme-linked immunosorbent assay test was performed on serum samples of 24 cases of erosive oral LP, 29 cases of reticular oral LP, 30 cases of cutaneous LP and 30 healthy controls. The severity of oral LP was evaluated by Reticulation, Erosion and Ulceration scoring system. There were no significant differences in the concentrations of autoantibodies to Dsg1 between the four groups. Autoantibodies to Dsg3 were increased in erosive oral LP compared with healthy controls (p value = 0.005) but no increase was observed between other groups. We did not detect a correlation between the severity of the disease and the levels of anti-Dsg1 and 3 in patients with erosive and reticular types of oral LP. In conclusion, regardless of the increased level of anti-Dsg3 antibody in erosive oral LP, serum concentrations of antibodies were under cut-off values. Moreover, the pathogenic role of anti-Dsg3 antibodies in erosive oral LP is uncertain.

Agarwal R, Saraswat A (2002) Oral lichen planus: an update. Drugs Today (Barc) 38(8):533–547CrossRef

Chainani-Wu N, Silverman S Jr, Reingold A, Bostrom A, Lozada-Nur F, Weintraub J (2008) Validation of instruments to measure the symptoms and signs of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105(1):51–58. doi:10.1016/j.tripleo.2007.06.022 CrossRefPubMed

D’Agosto G, Latini A, Carducci M, Mastroianni A, Vento A, Fei PC (2004) Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases. Clin Diagn Lab Immunol 11(4):762–765. doi:10.1128/CDLI.11.4.762-765.2004 PubMedPubMedCentral

Eversole LR (1997) Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis. Semin Cutan Med Surg 16(4):284–294CrossRefPubMed

Gholizadeh N, Khoini Poorfar H, TaghaviZenouz A, Vatandoost M, Mehdipour M (2015) Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol 10(2):136–140PubMedPubMedCentral

Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM (2001) The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 144(4):775–780CrossRefPubMed

Herrero-González JE, Parera Amer E, Segura S, Mas Bosch V, Pujol RM, Martínez Escala ME (2016) Epithelial antigenic specificities of circulating autoantibodies in mucosal lichen planus. Int J Dermatol 55(6):634–639. doi:10.1111/ijd.12990 CrossRefPubMed

Ingafou M, Lodi G, Olsen I, Porter SR (1997) Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 84(2):175–178CrossRefPubMed

Jamora MJ, Jiao D, Bystryn JC (2003) Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 48(6):976–977. doi:10.1067/mjd.20030438 CrossRefPubMed

10.

Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K, Hisata K, Iwatsuki K (2012) Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance. Br J Dermatol 167(2):252–261. doi:10.1111/j.1365-2133.2012.10929.x CrossRefPubMed

11.

Kato T, Fujimoto N, Uenishi T, Tanaka T (2009) A case of oral lichen planus in a patient with anti-desmoglein antibodies. Skin Res 8:173–176

12.

Kinjyo C, Kaneko T, Korekawa A, Rokunohe A, Aizu T, Matsuzaki Y, Nakano H, Sawamura D (2015) Oral lichen planus with antibodies to desmogleins 1 and 3. J Dermatol 42(1):40–41. doi:10.1111/1346-8138.12661 CrossRefPubMed

13.

Kishimoto K, Konno Y, Nakamura K, Kaneko F (2005) A case of oral lichen planus showing antibodies for desmoglein 1 and BP180 NC16a. Rinsho Derma 47:741–744

14.

Lamey PJ, McCartan BE, MacDonald DG, MacKie RM (1995) Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(1):44–49CrossRefPubMed

15.

Lin SC, Sun A, Wu YC, Chiang CP (1992) Presence of anti-basal cell antibodies in oral lichen planus. J Am Acad Dermatol 26(6):943–947CrossRefPubMed

16.

Lukac J, Brozović S, Vucicević-Boras V, Mravak-Stipetić M, Malenica B, Kusić Z (2006) Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus. Croat Med J 47(1):53–58PubMedPubMedCentral

17.

Mutasim DF, Adams BB (2001) Immunofluorescence in dermatology. J Am Acad Dermatol 45(6):803–822. doi:10.1067/mjd.2001.117518 (quiz 822–4) CrossRefPubMed

18.

Muramatsu K, Nishie W, Natsuga K, Fujita Y, Iwata H, Yamada T, Yamashita E, Asaka T, Shimizu H (2016) Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. J Dermatol 43(11):1350–1353. doi:10.1111/1346-8138.13493 CrossRefPubMed

19.

Park HK, Hurwitz S, Woo SB (2012) Oral lichen planus: REU scoring system correlates with pain. Oral Surg Oral Med Oral Pathol Oral Radiol 114(1):75–82. doi:10.1016/j.oooo.2012.02.013 CrossRefPubMed

20.

Piboonniyom SO, Treister N, Pitiphat W, Woo SB (2005) Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99(6):696–703. doi:10.1016/j.tripleo.2004.07.013 CrossRefPubMed

21.

Schiødt M, Holmstrup P, Dabelsteen E, Ullman S (1981) Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia. Oral Surg Oral Med Oral Pathol 51(6):603–608CrossRefPubMed

22.

Shiohara T, Kano Y, Jean L (2012) Lichen planus and lichenoid dermatoses. In: Bolognia JL, Jorizzo JL, Schaffer JV (eds) Dermathology, 3rd edn. Saunders/Elsevier, New York, p 192

23.

Shipman AR, Cooper S, Wojnarowska F (2011) Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus? Clin Exp Dermatol 36(3):267–269. doi:10.1111/j.1365-2230.2010.03878.x CrossRefPubMed

24.

Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K (1998) Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 110(1):76–78. doi:10.1046/j.1523-1747.1998.00085.x CrossRefPubMed

25.

Stanley JR (1989) Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest 83(5):1443–1448. doi:10.1172/JCI114036 CrossRefPubMedPubMedCentral

26.

Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365CrossRefPubMed

Title: Autoantibodies to desmogleins 1 and 3 in patients with lichen planus
Authors: Lajevardi Vahide
Halaji Zahra
Ghaedi Forugh
Saljoughi Nazi
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Archives of Dermatological Research / Issue 7/2017
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-017-1756-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Autoantibodies to desmogleins 1 and 3 in patients with lichen planus

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2017

Rituximab treatment in pemphigus vulgaris: effect on circulating Tregs

In vitro modeling of unsaturated free fatty acid-mediated tissue impairments seen in acne lesions

Erratum to: Autoantibodies to desmogleins 1 and 3 in patients with lichen planus

The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease

Topical application of Dermatophagoides farinae or oxazolone induces symptoms of atopic dermatitis in the rabbit ear

Subclinical cutaneous inflammation remained after permeability barrier disruption enhances UV sensitivity by altering ER stress responses and topical pseudoceramide prevents them